Ramucirumab - Eli Lilly and Company
At a glance
- Drug Originator Dyax
- Drug Licenced by Eli Lilly and Company; Innovent Biologics
- Drug Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Vascular endothelial growth factor receptor-2 antagonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 82
- BLAs 1
- International Patents 1,162
Disclaimer